Michael E. Brier

University of Louisville — United States

Medicine · Health Sciences

30h-index3.4kcitations147works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Dialysis and Renal Disease Management(28), Erythropoietin and Anemia Treatment(28), Antibiotics Pharmacokinetics and Efficacy(17), Central Venous Catheters and Hemodialysis(15), Chronic Kidney Disease and Diabetes(10)

Publications147 total

An Artificial Intelligence-Based Program Significantly Reduces ESA (Erythropoiesis-Stimulating Agent) Use and Maintains Hemoglobin
Journal of the American Society of Nephrology·2024· 2 cited
Modeling Progression of Uremic Vasculopathy Using Machine Learning
Journal of the American Society of Nephrology·2024
Leveraging quantitative systems pharmacology and artificial intelligence to advance treatment of chronic kidney disease mineral bone disorder
American Journal of Physiology-Renal Physiology·2024· 3 cited
Application of artificial intelligence to chronic kidney disease mineral bone disorder
Clinical Kidney Journal·2024· 4 citedOpen Access
Artificial Intelligence Prediction of Dialysis Access Complications
Journal of the American Society of Nephrology·2023
Improving Treatment of CKD-Mineral Bone Disorder (CKD-MBD) Through the Incorporation of Agatston Scores
Journal of the American Society of Nephrology·2023
Predicting Hemodialysis Arteriovenous (AV) Access Stenosis Using Artificial Intelligence
Journal of the American Society of Nephrology·2022
Predicting In-Hospital Mortality Among COVID-19 Pneumonia Patients With AKI
Journal of the American Society of Nephrology·2022
Glomerular Annexin A3 and Cathepsin C Staining in COVID-19-Associated and HIV-Associated Nephropathy (HIVAN)-Associated Collapsing Glomerulopathy
Journal of the American Society of Nephrology·2022
Artificial Intelligence (AI) Tool Decreases Epoetin Beta (Mircera) Drug Exposure and Maintains Hemoglobin at Desired Levels
Journal of the American Society of Nephrology·2022
Impact of Targeting Bone Mineral Flow on Achievement of KDIGO Guidelines for CKD-MBD
Journal of the American Society of Nephrology·2022
Discontinuation of Artificial Intelligence (AI) Tool for Anemia Management Results in Higher Drug Exposure, Lower Hemoglobin (Hb)
Journal of the American Society of Nephrology·2022
Artificial intelligence–guided precision treatment of chronic kidney <scp>disease</scp>–<scp>mineral</scp> bone disorder
CPT Pharmacometrics & Systems Pharmacology·2022· 15 citedOpen Access
Differential Functional Responses of Neutrophil Subsets in Severe COVID-19 Patients
Frontiers in Immunology·2022· 22 citedOpen Access
Use of Artificial Intelligence to Identify New Mechanisms and Approaches to Therapy of Bone Disorders Associated With Chronic Kidney Disease
Frontiers in Medicine·2022· 7 citedOpen Access
Artificial Intelligence in Medicine in Anemia
Artificial Intelligence in Medicine·2022· 1 cited
Use of Artificial Intelligence/Machine Learning for Individualization of Drug Dosing in Dialysis Patients
2022· 1 cited
Development of a Machine Learning Approach to Management of CKD-MBD Therapy
Journal of the American Society of Nephrology·2021· 1 cited
Na/H Exchange Regulatory Factor 1 Deficient Mice Show Evidence of Oxidative Stress and Altered Cisplatin Pharmacokinetics
Antioxidants·2021· 5 citedOpen Access
Plasma Cytokine Profiling to Predict Steroid Resistance in Pediatric Nephrotic Syndrome
Kidney International Reports·2021· 13 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

George R. Aronoff(25), Adam E. Gawęda(12), Rebecca Sloan(8), Friedrich C. Luft(8), Alfred A. Jacobs(8), Thomas A. Golper(5), Kenneth R. McLeish(5), Jon B. Klein(4), Martin Bunke(3), C. Martin Bunke(3), Amy C. Dwyer(3), Michael L. Merchant(3), Richard Ward(3), William E. Smoyer(2), Dennis J. Stalker(2), Jacek M. Zurada(2), Mehmet K. Muezzinoglu(2), Ming Li(2), Daniel W. Wilkey(2), Deepa H. Chand(2)